Figure 2.
Veterans Affairs Rheumatoid Arthritis (VARA) registry population with full breakdown subjects fulfilling inclusion criteria and the fraction of subjects with high (medication possession ratio (MPR) ≥0.80) and low adherence (MPR <080) to methotrexate (MTX).
*Percent of veterans from the 455 who met inclusion criteria